furegrelate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
furegrelate: structure given in UD 35:175:d
| Excerpt | Relevance | Reference |
|---|---|---|
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 7.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 3.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCarthy, ET | 1 |
| Sharma, M | 1 |
1 other study available for furegrelate and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Albumins; Animals; Anti-Inflamma | 2002 |